129 related articles for article (PubMed ID: 34935238)
1. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report.
Rogenhofer N; Mahner S; von Hasselbach YL; Thaler CJ
Am J Reprod Immunol; 2022 Feb; 87(2):e13506. PubMed ID: 34935238
[TBL] [Abstract][Full Text] [Related]
2. Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitro.
von Schönfeldt V; Rogenhofer N; Ruf K; Thaler CJ; Jeschke U
J Reprod Immunol; 2016 Sep; 117():52-6. PubMed ID: 27472296
[TBL] [Abstract][Full Text] [Related]
3. Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages.
Ye Y; Kuhn C; Kösters M; Arnold GJ; Ishikawa-Ankerhold H; Schulz C; Rogenhofer N; Thaler CJ; Mahner S; Fröhlich T; Jeschke U; von Schönfeldt V
EBioMedicine; 2019 Mar; 41():610-622. PubMed ID: 30827932
[TBL] [Abstract][Full Text] [Related]
4. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
Rogenhofer N; von Schönfeldt V; Ochsenkühn R; Sili F; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
[TBL] [Abstract][Full Text] [Related]
5. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
7. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
9. Intralipid treatment for women with reproductive failures.
Coulam CB
Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
[TBL] [Abstract][Full Text] [Related]
11. Intralipid therapy and adverse reproductive outcome: is there any evidence?
Kumar P; Marron K; Harrity C
Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose ovarian stimulation with HMG plus progesterone on pregnancy outcome in women with history of recurrent pregnancy loss and secondary infertility: a retrospective cohort study.
Coccia ME; Rizzello F; Cozzolino M; Turillazzi V; Capezzuoli T
Gynecol Endocrinol; 2018 Jun; 34(6):528-531. PubMed ID: 29433402
[TBL] [Abstract][Full Text] [Related]
13. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
[TBL] [Abstract][Full Text] [Related]
15. Antinuclear Antibodies predict a higher number of Pregnancy Loss in Unexplained Recurrent Pregnancy Loss.
Sakthiswary R; Rajalingam S; Norazman MR; Hussein H
Clin Ter; 2015; 166(2):e98-101. PubMed ID: 25945451
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Study on the Expression of G-CSF, G-CSFR, VEGF, VEGFR-1, Foxp3 in First Trimester Trophoblast of Recurrent Pregnancy Loss in Pregnancies Treated with G-CSF and Controls.
Scarpellini F; Klinger FG; Rossi G; Sbracia M
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906232
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing of products of conception in recurrent pregnancy loss evaluation.
Dahdouh EM; Kutteh WH
Reprod Biomed Online; 2021 Jul; 43(1):120-126. PubMed ID: 33926784
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
19. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
Yang X; Meng T
J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
[TBL] [Abstract][Full Text] [Related]
20. Recurrent pregnancy loss and obesity.
Sugiura-Ogasawara M
Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):489-97. PubMed ID: 25589398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
